| Literature DB >> 17266176 |
Minka Breloer1, Birte Kretschmer, Katja Lüthje, Svenja Ehrlich, Uwe Ritter, Thomas Bickert, Christiane Steeg, Simon Fillatreau, Kai Hoehlig, Vassiliki Lampropoulou, Bernhard Fleischer.
Abstract
The transmembrane glycoprotein CD83 has been described as a specific maturation marker for dendritic cells and several lines of evidence suggest that CD83 regulates thymic T cell maturation as well as peripheral T cell activation. Here we show for the first time that CD83 is involved also in the regulation of B cell function. CD83 is up-regulated on activated B cells in vivo, specifically in the draining lymph nodes of Leishmania major-infected mice. The ubiquitous transgenic (Tg) expression of CD83 interferes with Leishmania-specific T cell-dependent and with T cell-independent antibody production. This defect is restricted to the B cell population since the antigen-specific T cell response of CD83Tg mice to L. major infection is unchanged. The defective immunoglobulin (Ig) response is due to Tg expression of CD83 on the B cells because wild-type B cells display normal antigen-specific responses in CD83Tg hosts and CD83Tg B cells do not respond to immunization in a mixed wild-type/CD83Tg bone marrow chimera. Finally, the treatment of non-Tg C57BL/6 mice with anti-CD83 mAb induces a dramatic increase in the antigen-specific IgG response to immunization, thus demonstrating a regulatory role for naturally induced CD83 on wild-type B cells.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17266176 DOI: 10.1002/eji.200636852
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532